180 related articles for article (PubMed ID: 38075074)
1. Genetically predicted serum testosterone and risk of gynecological disorders: a Mendelian randomization study.
Zhao B; Wang Z; Liu D; Zhang S
Front Endocrinol (Lausanne); 2023; 14():1161356. PubMed ID: 38075074
[TBL] [Abstract][Full Text] [Related]
2. Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.
Guixue G; Yifu P; Xiaofeng T; Qian S; Yuan G; Wen Y; Conghui H; Zuobin Z
Front Endocrinol (Lausanne); 2024; 15():1337562. PubMed ID: 38375192
[TBL] [Abstract][Full Text] [Related]
3. No evidence of genetic causal association between sex hormone-related traits and systemic lupus erythematosus: A two-sample Mendelian randomization study.
Yuan G; Yang M; Xie J; Xu K; Zhang F
Clin Rheumatol; 2023 Dec; 42(12):3237-3249. PubMed ID: 37495778
[TBL] [Abstract][Full Text] [Related]
4. Epidemiologic and genetic associations of female reproductive disorders with depression or dysthymia: a Mendelian randomization study.
Ling S; Dai Y; Weng R; Li Y; Wu W; Zhou Z; Zhong Z; Zheng Y
Sci Rep; 2024 Mar; 14(1):5984. PubMed ID: 38472314
[TBL] [Abstract][Full Text] [Related]
5. The causal effects of genetically predicted alcohol consumption on endometrial cancer risk from a Mendelian randomization study.
Yang J; Qu X; Zheng AJ; Jiang F; Chang H; Zhang JR; Yan LJ; Ning P
Sci Rep; 2024 Feb; 14(1):3478. PubMed ID: 38347022
[TBL] [Abstract][Full Text] [Related]
6. Mendelian randomization analyses identified bioavailable testosterone mediates the effect of sex hormone-binding globulin on prostate cancer.
Wan B; Lu L; Lv C
Andrology; 2023 Sep; 11(6):1023-1030. PubMed ID: 36524281
[TBL] [Abstract][Full Text] [Related]
7. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
[TBL] [Abstract][Full Text] [Related]
8. Health outcomes of age at menarche in European women: a two-sample Mendelian randomization study.
Lv Y; Xia X; Lei L; Xiang W; Wu X; Xie S; Li J
Postgrad Med J; 2023 Aug; 99(1175):993-999. PubMed ID: 37302123
[TBL] [Abstract][Full Text] [Related]
9. Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study.
Sun S; Jiao M; Han C; Zhang Q; Shi W; Shi J; Li X
Front Endocrinol (Lausanne); 2020; 11():621. PubMed ID: 33013699
[No Abstract] [Full Text] [Related]
10. Assessing the Casual Association between Sex Hormone Levels and Fracture Risk: A Two-Sample Mendelian Randomization Study.
Sun K; Ming Y; Xu J; Wu Y; Zeng Y; Wu L; Li M; Shen B
Orthop Surg; 2023 Dec; 15(12):3065-3074. PubMed ID: 37771125
[TBL] [Abstract][Full Text] [Related]
11. Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis.
Hazelwood E; Sanderson E; Tan VY; Ruth KS; Frayling TM; Dimou N; Gunter MJ; Dossus L; Newton C; Ryan N; Pournaras DJ; O'Mara TA; Davey Smith G; Martin RM; Yarmolinsky J
BMC Med; 2022 Apr; 20(1):125. PubMed ID: 35436960
[TBL] [Abstract][Full Text] [Related]
12. The Genetic Association of Polycystic Ovary Syndrome and the Risk of Endometrial Cancer: A Mendelian Randomization Study.
Chen H; Zhang Y; Li S; Tao Y; Gao R; Xu W; Yang Y; Cheng K; Wang Y; Qin L
Front Endocrinol (Lausanne); 2021; 12():756137. PubMed ID: 34803918
[TBL] [Abstract][Full Text] [Related]
13. Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization.
Zhu T; Goodarzi MO
J Clin Endocrinol Metab; 2022 Feb; 107(3):e899-e911. PubMed ID: 34669940
[TBL] [Abstract][Full Text] [Related]
14. Circulating sex hormone-binding globulin levels and ischemic stroke risk: a Mendelian randomization study.
Zeng Y; Cao S; Yang H
Postgrad Med J; 2023 Nov; 99(1178):1272-1279. PubMed ID: 37742091
[TBL] [Abstract][Full Text] [Related]
15. Evidence for causal effects of polycystic ovary syndrome on oxidative stress: a two-sample mendelian randomisation study.
Yifu P
BMC Med Genomics; 2023 Jun; 16(1):141. PubMed ID: 37337194
[TBL] [Abstract][Full Text] [Related]
16. Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome.
Chen S; Guo Z; Yu Q
Hum Genomics; 2023 Nov; 17(1):100. PubMed ID: 37957681
[TBL] [Abstract][Full Text] [Related]
17. The effect of androgens on the risk of endometriosis sub-phenotypes and ovarian neoplasms: A Mendelian randomization study.
Gjorgoska M; Rizner TL
J Steroid Biochem Mol Biol; 2024 May; 239():106482. PubMed ID: 38369034
[TBL] [Abstract][Full Text] [Related]
18. Causal association between low vitamin D and polycystic ovary syndrome: a bidirectional mendelian randomization study.
Gao B; Zhang C; Wang D; Li B; Shan Z; Teng W; Li J
J Ovarian Res; 2024 May; 17(1):95. PubMed ID: 38715063
[TBL] [Abstract][Full Text] [Related]
19. Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus.
Kho PF; Mortlock S; ; ; Rogers PAW; Nyholt DR; Montgomery GW; Spurdle AB; Glubb DM; O'Mara TA
Hum Genet; 2021 Sep; 140(9):1353-1365. PubMed ID: 34268601
[TBL] [Abstract][Full Text] [Related]
20. Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses.
Mullee A; Dimou N; Allen N; O'Mara T; Gunter MJ; Murphy N
Br J Cancer; 2021 Oct; 125(9):1308-1317. PubMed ID: 34363033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
